Chief Restructuring Officer of a company providing non-medical cosmetic treatment services with over 200 centers and 3,000 staff across Asia, including China. Work involved review of operations to identify businesses to retain, dispose or restructure. This led to the divestment of certain businesses in certain locations and restructuring the retained operations. As a result, the business was stablised and returned to strong performance, resulting in a sale to a Private Equity investor. Borrelli Walsh representatives remain involved on the Board today.
Chief Restructuring Officer, Operational Turnaround & Sale